Evidence-Based Complementary and Alternative Medicine

Natural Products for Liver Diseases: Basic, Clinical, and Translational Research


Publishing date
21 Sep 2012
Status
Published
Submission deadline
04 May 2012

Lead Editor

1Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

2Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong


Natural Products for Liver Diseases: Basic, Clinical, and Translational Research

Description

The liver is the largest solid organ in the body, and it is also considered a gland because among its many functions, it makes and secretes bile. Liver disease is any condition that may cause liver inflammation or tissue damage and affects liver function. Liver disease is categorized both by the cause and the effect it has on the liver. Causes may include infection, injury, exposure to drugs or toxic compounds, an autoimmune process, or a genetic defect that leads to the deposition and buildup of damaging substances such as iron or copper. Effects may include inflammation, scarring, obstructions, clotting abnormalities, and liver failure.

A natural product is a chemical compound or substance produced by a living organism found in nature that usually has pharmacological or biological activities for use in pharmaceutical drug discovery and drug design. The literature indicates that many natural products are available as chemoprotective agents against commonly occurring liver diseases such as hepatitis, cirrhosis, liver cancer, fatty liver diseases, and gallstones. These natural products are found in vegetables, fruits, plant extracts, herbs, insects, and animals.

We invite authors to submit original research and review articles regarding the basic, clinical, and translational research on natural products in prevention and treatment of various liver diseases. Papers should be important to researchers/clinicians in its field, interesting to scientists/clinicians outside the field, and with rigorous methodology and substantial evidence for its conclusions. Potential topics include, but are not limited to:

  • Pharmacognosy, pharmacology, and pharmacokinetics of natural products-derived ingredients or extracts that could be used to treat liver diseases
  • In vivo or in vitro experimental studies verifying the effects of natural products or natural products-derived ingredients or extracts in treating liver diseases
  • New points in extracting, identifying, and preparing natural products-derived ingredients or medicines that could be used to treat liver diseases
  • The role of natural products-derived medicines in prevention and treatment of liver diseases in clinical practice
  • New dosage form or new method of application of natural products-derived medicines that may have better effects in clinical practice

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 794343
  • - Editorial

Natural Products for Liver Diseases: Basic, Clinical, and Translational Research

Chang-Quan Ling | Jen-Hwey Chiu | ... | William C. S. Cho
  • Special Issue
  • - Volume 2012
  • - Article ID 329171
  • - Research Article

Effects of Lipid Regulation Using Raw and Processed Radix Polygoni Multiflori in Rats Fed a High-Fat Diet

Na Li | Zhen Chen | ... | Ronghua Zhao
  • Special Issue
  • - Volume 2012
  • - Article ID 216061
  • - Research Article

Hepatoprotective Activity of the Total Saponins from Actinidia valvata Dunn Root against Carbon Tetrachloride-Induced Liver Damage in Mice

Liping Qu | Hailiang Xin | ... | Changquan Ling
  • Special Issue
  • - Volume 2012
  • - Article ID 843048
  • - Research Article

Metabolic Profiling Study of Yang Deficiency Syndrome in Hepatocellular Carcinoma by NMR and Pattern Recognition

Xueqiang Huang | Qunwei Chen | ... | Changquan Ling
  • Special Issue
  • - Volume 2012
  • - Article ID 607675
  • - Research Article

Polygonum cuspidatum Extract Induces Anoikis in Hepatocarcinoma Cells Associated with Generation of Reactive Oxygen Species and Downregulation of Focal Adhesion Kinase

Bing Hu | Hong-Mei An | ... | Shan Deng
  • Special Issue
  • - Volume 2012
  • - Article ID 837939
  • - Review Article

Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease

Anna Del Prete | Antonella Scalera | ... | Carmelina Loguercio
  • Special Issue
  • - Volume 2012
  • - Article ID 417953
  • - Research Article

Hepatoprotective Activity of Elephantopus scaber on Alcohol-Induced Liver Damage in Mice

Wan Yong Ho | Swee Keong Yeap | ... | Noorjahan Banu Alitheen
  • Special Issue
  • - Volume 2012
  • - Article ID 432814
  • - Research Article

Total Saponin from Root of Actinidia valvata Dunn Inhibits Hepatoma 22 Growth and Metastasis In Vivo by Suppression Angiogenesis

Guo-Yin Zheng | Hai-Liang Xin | ... | Chang-Quan Ling
  • Special Issue
  • - Volume 2012
  • - Article ID 284963
  • - Research Article

The Chinese Herbal Decoction Danggui Buxue Tang Inhibits Angiogenesis in a Rat Model of Liver Fibrosis

Jing Lv | Zhimin Zhao | ... | Chenghai Liu
  • Special Issue
  • - Volume 2012
  • - Article ID 256561
  • - Research Article

Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models

Li-Jen Su | Chih-Hsueh Yang | ... | Chi-Ying F. Huang
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate26%
Submission to final decision70 days
Acceptance to publication39 days
CiteScore2.010
Impact Factor1.984
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.